Clinical Trial

Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx

Study acronym: DECT-CEco
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 15, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The diagnostic and pre-therapeutic assessment of squamous cell carcinomas requires a neck and chest CT scan and a neck and facial MRI, which is the most effective examination, to establish the TNM stage of the tumor. However, obtaining this complete assessment can delay treatment. Confirmation of the non-inferiority of 40keV dual-energy CT in BOLT compared to MRI would spare the patient an additional MRI examination, speed up the pre-treatment assessment, reduce the loss of opportunity due to delayed treatment, and free up MRI imaging slots, which are still insufficient in the region.
Trial Details
NCT Number NCT07343271
Lead Sponsor University Hospital, Strasbourg, France
Conditions Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma
Enrollment 30 participants
Start Date 2025-07-11
Primary Completion 2026-07 (estimated)
Study Completion 2026-07-11 (estimated)
Updated on ClinicalTrials.gov 2026-01-15